) 13.82% Administrative expenses (11.29) (7.77) 3.51 -31.13% Share of gain of investments in associate 0.03 0.03 0.00 0.25% Finance costs (0.08) (0.06) 0.02 -22.49% Profit before income tax expense 30.31

(16.38) (15.75) Cost of sales of goods 81.76 78.62 68.69 78.40 (13.07) (15.99) Gross profit 22.23 21.38 18.92 21.60 (3.31) (14.89) Other income 1.32 1.27 1.07 1.22 (0.25) (18.93) Gain on exchange rate

146.47% Profit before income tax expenses 42.67 111.79 (69.11) -61.83% Income tax expenses (revenues) 1.27 0.58 0.69 119.50% Profit for the year 41.40 111.21 (69.81) -62.77% Unrealised gain on revaluation

) Financial costs 0.02 0.01 0.01 dt -6t 0.02 0.01 0.01 87.87 Total Expenses 5l 82 35.91 1.91 5.29 2a EO 36.24 1.34 3.70 Profit before share loss from investment in joint venture and income tax 2.83 4.74 (1 .91

be a potential market in the future. For Medical Devices; There is still intense competition in both domestic and foreign markets. Market leaders use price strategies to gain market share. But the

amounting to THB 1.9 million due to the fact that in 2018 Company had gain from exchange rate and advertising revenue. Cost of sales or service and Gross profit Unit : THB million For the year ended 2019 2018

concrete, special cement and architecture was increased by Baht 118.99 million. (2) Other incomes The Company and its subsidiaries recognized dividend income for Baht 2.40 million and gain the profit from

-recurring items 135.5 18.9 (3.3) (0.2) (102.4%) 1 Adjusted EBITDA for any year/period is defined as Profit (loss) before income taxes plus Finance costs, plus Depreciation and Amortization, deduct (plus) gain

% Cost of sales (290.46 ) (600.93 ) 310.47 (51.66%) (98.17%) (84.80%) GROSS PROFIT 5.42 107.69 (102.27 ) (94.96%) 1.83% 15.20% Distribution costs (26.13 ) (35.11 ) (8.98 ) 25.58% (8.83%) (4.95

% 100.00% Cost of sales (290.46 ) (600.93 ) 310.47 (51.66%) (98.17%) (84.80%) GROSS PROFIT 5.42 107.69 (102.27 ) (94.96%) 1.83% 15.20% Distribution costs (26.13 ) (35.11 ) (8.98 ) 25.58% (8.83%) (4.95